Problem Solving Treatment for Diabetes in Individuals With Poor Diabetes Control
NCT05651490 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2022-12-15
Summary
The goal of this randomised controlled trial is to test a cognitive-behavioural intervention, Problem Solving Treatment for Diabetes (PST-D) in patients with type 2 diabetes. The main questions it aims to answer are:
* To evaluate the clinical effectiveness of PST-D compared with the attention control group.
* To determine the impact of PST-D on patient-centred, behavioural, and psychosocial outcomes.
* To identify independent factors associated with an improvement in HbA1c and reductions in incidence and progression diabetic retinopathy, diabetic neuropathy, diabetic peripheral neuropathy, and visual impairment at 18-month follow-up in both groups; and determine if these factors mediate the associations between the PST-D intervention with the above outcomes.
* To quantify the incremental cost-effectiveness of PST-D compared with the attention control group at 18-month follow-up.
* To understand participants' views, experiences, and opinions about PST-D; and the barriers and facilitators to program completion.
Participants will complete blood tests, ocular examinations, and a series of questionnaires at baseline, 6-month, 12-month, and 18-month follow-up. Participants will also complete the intervention/ control group sessions conducted over the phone, video call, or face-to-face depending on the participant's preference.
Researchers will compare the intervention group against the attention control group to determine the effectiveness of PST-D on improving clinical, patient-centred, behavioural, and psychosocial outcomes.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- BEHAVIORAL
-
Problem Solving Treatment for Diabetes
In the introductory session, the structure of and rationale behind PST-D will be explained. The specialist will work with the participant to develop a problem list related to diabetes self-management and smoking cessation, if applicable. During the weekly sessions, the participant will be taught and guided through the seven steps of problem solving: 1. Clarifying and defining the problem 2. Setting a realistic goal 3. Brainstorming multiple solutions 4. Generating pros and cons for each solution 5. Evaluating and choosing a preferred solution 6. Developing a specific action plan to implement the solution 7. Evaluating outcomes from the previous session. Participants will also plan to engage in at least 1 enjoyable activity daily during the week. The number of sessions will differ based on the specialist's assessment of the participant's problem-solving skills. Maintenance sessions will be delivered monthly across 3 months in order to follow-up with participants.
- BEHAVIORAL
-
Attention Control Group
During the sessions, the healthcare practitioners will provide general information and recommendations on general health topics such as oral health, hearing loss, sleep, dementia, adult vaccination, influenza, and dengue fever. Participants will also be given handouts adapted from government agencies and/or public bodies, such as HealthHub, National Health Service, National Addictions Management Service, and National Environmental Agency, on these topics. The healthcare practitioners will avoid discussing topics related to diabetes, diet, physical activity, and medication.
Sponsors & Collaborators
-
Singapore Eye Research Institute
lead OTHER
Principal Investigators
-
Ecosse Lamoureux, PhD · Singapore Eye Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-09
- Primary Completion
- 2024-03-31
- Completion
- 2024-03-31
Countries
- Singapore
Study Locations
More Related Trials
-
Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring
NCT06607497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
NCT05770687 ·Status: RECRUITING
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The SongDance Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment
NCT03576430 ·Status: UNKNOWN ·Phase: NA
-
Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)
NCT04304261 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Medicine in Chinese Patients With Young Onset Diabetes
NCT04049149 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2
NCT02359461 ·Status: COMPLETED ·Phase: NA
-
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191 ·Status: ACTIVE_NOT_RECRUITING
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT02838693 ·Status: UNKNOWN
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968 ·Status: RECRUITING ·Phase: NA
-
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
NCT00814190 ·Status: COMPLETED ·Phase: NA
-
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NCT05147961 ·Status: RECRUITING ·Phase: NA
-
An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients
NCT01360697 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China
NCT01525693 ·Status: UNKNOWN
-
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus
NCT05631561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes
NCT05341388 ·Status: TERMINATED
-
Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
NCT00891124 ·Status: COMPLETED
-
Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes
NCT01505036 ·Status: COMPLETED ·Phase: NA
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED
-
Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
NCT04541797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus
NCT01887067 ·Status: TERMINATED ·Phase: NA
-
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia
NCT01934686 ·Status: COMPLETED
-
Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus
NCT05673668 ·Status: UNKNOWN ·Phase: NA